Company: STAA
Filing Date: 2025-11-10
Form Type: DFAN14A
Source: 0001213900-25-108281
Chunk: 3

Company: STAAR SURGICAL CO
Filing Date: 2025-11-10
Form: DFAN14A
Chunk 3
---
iative measures.

As STAAR’s largest shareholder,
we have been asking for weeks for the Board to engage in dialogue with shareholders and for changes to the Board so that truly independent
directors could assist in the evaluation of the best path forward. This Board has confounded us and our fellow shareholders with its myriad,
and apparently conflict-ridden, decisions and lack of transparency, including about other strategic interest in the Company. Given these
missteps, and the lack of sufficient public company sale experience on the Board, having new directors to ensure there are no further
false starts, delays, misrepresentations, or mistakes is more critical than ever in our view.

We understand that the founder of one
of STAAR’s largest shareholders, Yunqi Capital, has expressed an interest in serving on the Board. And we remain willing to identify
other qualified and independent candidates for the Board, including candidates who have experience overseeing well-managed sale processes
and have a strong understanding of directors’ fiduciary duties to shareholders.

The Board should have some humility.
It repeatedly and vociferously recommended the Alcon deal, which was roundly and overwhelmingly rejected by shareholders and proxy advisory
firms alike. In a continuing scramble to salvage its ill-conceived deal, the Board has now delayed the shareholder vote three separate
times. Dare we say, the problem lies with the Board, not with the shareholders; all the delays and patches and band-aids just underscore
that point.

As the Board can surely appreciate,
we have lost confidence in the Board’s ability to make good and objective decisions on our behalf. The right, humble, and necessary
response is for this Board to embrace accountability and sound governance by augmenting its membership with new directors whom investors
can trust. Absent such a responsible move, we believe shareholders will doubt the outcome of this appended go-shop ‘fix-er-up’
process, and the credibility of the Board will be even further damaged in the eyes of shareholders.”

Shareholders can find additional information at www.LetSTAARShine.com.

About Broadwood

Broadwood Partners, L.P. is managed by Broadwood
Capital, Inc. Broadwood Capital is a private investment firm based in New York City. Neal Bradsher is the President of Broadwood Capital.

Certain Information Concerning the Participants

Broadwood Partners, L.P., Broadwood Capital, Inc.,
Neal C. Bradsher, Richard T. LeBuhn, Natalie R. Capasso, Raymond A. Myers and Jason J. Martin (